Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Cancer Research and Treatment
|
May 23, 2014
Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee
Kyung A Kwon, Sung Yong Oh, Ho Young Kim, et al.
Medicine
|
August 13, 2015
Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer
Dong Soo Lee, Seung Joon Kim, Hong Seok Jang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 1, 2025
Improved Prognostic Stratification With 2023 International Federation of Gynecology and Obstetrics Staging in Endometrial Cancer Reflecting Poor Prognosis of Aggressive Histological Types and p53 Abnormality
Miseon Lee, Heesoo Yoon, Ujae Kim, et al.
Cancer Research and Treatment
|
July 21, 2014
A case-control study to identify risk factors for totally implantable central venous port-related bloodstream infection
Guk Jin Lee, Sook Hee Hong, Sang Young Roh, et al.
Microbiology and Immunology
|
July 22, 2006
Immunostimulating factor isolated from actinobacillus actinomycetemcomitans stimulates monocytes and inflammatory macrophages
Wol-Soon Jo, Sung-Tae Yee, Sik Yoon, et al.
Cancer Research and Treatment
|
September 12, 2009
Autologous stem cell transplantation using a modified TAM conditioning regimen for clinically aggressive non-Hodgkin's lymphoma
Sook Hee Hong, Young Seon Hong, In Sook Woo, et al.
BMC Cancer
|
January 6, 2021
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
Seo Ree Kim, Sang Hoon Chun, Joo Ri Kim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 13, 2026
Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials
Dong Hyun Kim, Miso Kim, Jeonghwan Youk, et al.
Gynecologic Oncology
|
December 3, 2014
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10
Sook Hee Hong, Soohyeon Lee, Hoon-Gu Kim, et al.
Clinical Lung Cancer
|
March 20, 2016
Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer
In-Ho Kim, In Hee Lee, Ji Eun Lee, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Cancer Research and Treatment
|
May 23, 2014
Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee
Kyung A Kwon, Sung Yong Oh, Ho Young Kim, et al.
Medicine
|
August 13, 2015
Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer
Dong Soo Lee, Seung Joon Kim, Hong Seok Jang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 1, 2025
Improved Prognostic Stratification With 2023 International Federation of Gynecology and Obstetrics Staging in Endometrial Cancer Reflecting Poor Prognosis of Aggressive Histological Types and p53 Abnormality
Miseon Lee, Heesoo Yoon, Ujae Kim, et al.
Cancer Research and Treatment
|
July 21, 2014
A case-control study to identify risk factors for totally implantable central venous port-related bloodstream infection
Guk Jin Lee, Sook Hee Hong, Sang Young Roh, et al.
Microbiology and Immunology
|
July 22, 2006
Immunostimulating factor isolated from actinobacillus actinomycetemcomitans stimulates monocytes and inflammatory macrophages
Wol-Soon Jo, Sung-Tae Yee, Sik Yoon, et al.
Cancer Research and Treatment
|
September 12, 2009
Autologous stem cell transplantation using a modified TAM conditioning regimen for clinically aggressive non-Hodgkin's lymphoma
Sook Hee Hong, Young Seon Hong, In Sook Woo, et al.
BMC Cancer
|
January 6, 2021
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
Seo Ree Kim, Sang Hoon Chun, Joo Ri Kim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 13, 2026
Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials
Dong Hyun Kim, Miso Kim, Jeonghwan Youk, et al.
Gynecologic Oncology
|
December 3, 2014
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10
Sook Hee Hong, Soohyeon Lee, Hoon-Gu Kim, et al.
Clinical Lung Cancer
|
March 20, 2016
Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer
In-Ho Kim, In Hee Lee, Ji Eun Lee, et al.
Page
of 10